Co-Diagnostics, Inc.
CODX
$0.375
$0.01985.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.53% | 3.00% | 0.98% | -22.65% | -148.15% |
| Total Depreciation and Amortization | 11.93% | 9.61% | 3.72% | -7.87% | -4.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.78% | -24.22% | -27.69% | -38.88% | -52.15% |
| Change in Net Operating Assets | -51.17% | -46.84% | -81.41% | -53.14% | -8.89% |
| Cash from Operations | -32.03% | -20.60% | -67.98% | -244.60% | -436.17% |
| Capital Expenditure | 45.19% | 4.53% | -1.24% | -31.13% | 4.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.36% | 159.47% | 158.69% | 164.48% | 129.53% |
| Cash from Investing | 10.93% | 155.58% | 154.49% | 161.06% | 126.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 93.41% | 97.42% | 94.00% | 90.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.62% | 93.41% | 97.42% | 93.99% | 90.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.70% | 100.78% | 100.04% | 118.38% | 87.72% |